Companies similar to NEKTAR THERAPEUTICS (NKTR)
Health Care · NASDAQ
NEKTAR THERAPEUTICS (NKTR)'s closest peers include Regeneron Pharmaceuticals (REGN), Moderna (MRNA), VERTEX INC CLASS A (VERX), Biogen (BIIB) and Bristol Myers Squibb (BMY). This peer set is drawn from NKTR's enriched company profile and is informational only — not financial advice.
Similar companies
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
-
ModernaMRNAHealth Care
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…
$63.15 (as of 2026-07-16) · market cap $25.1B
-
VERTEX INC CLASS AVERXInformation Technology
Vertex automates and governs transaction-based indirect tax compliance across 195 countries for enterprises, embedded into their commerce systems to handle…
$13.16 (as of 2026-07-16) · market cap $2.1B
-
BiogenBIIBHealth Care
Biogen is a global biotechnology company developing and commercializing therapies across neurology, immunology, and rare genetic disease.
$208.92 (as of 2026-07-16) · market cap $30.3B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
Not quite? Describe exactly what you want →
Peers are drawn from NKTR's enriched profile (the same similarity signal the chat uses for "companies like NKTR"). See the full profile: NEKTAR THERAPEUTICS (NKTR).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.